Trademarkia Logo

Canada

C$
Trademark Search in Canada
MABLINK

View On IC.GC.CA

MABLINK
APPROVED

on 19 Feb 2025

Last Applicant/ Owned by

MABLINK BIOSCIENCE

14 rue Waldeck-RousseauF-69006 LYON

FR

Serial Number

2069670 filed on 15th Jul 2020

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

MABLINK

Trademark usage description

binding agents for bioconjugating cytotoxins, markers, highly active pharmaceutical ingredients, and monoclonal antibodies, for the treatment of cance Read More

Classification Information

Class [001]
Binding agents for bioconjugating cytotoxins, markers, highly active pharmaceutical ingredients, and monoclonal antibodies, for the treatment of cancer, lupus, Crohn's disease, sarcoidosis, gastritis, gout, viral infections, bacterial infections, and fungal infections; Cytotoxins, monoclonal antibodies, and highly active pharmaceutical ingredients for the treatment of cancer, lupus, Crohn's disease, sarcoidosis, gastritis, gout, viral infections, bacterial infections, and fungal infections; molecules and biomolecules, namely binding agents, markers, reagents, antibody fragments, antibodies, all intended for diagnosis for medical purposes; Monoclonal antibodies for cancer treatment.

Classification kind code

11

Class [005]
Pharmaceutical preparations used in the treatment of cancer, lupus, Crohn's disease, sarcoidosis, gastritis, and gout, pharmaceutical preparations for the treatment of viral infections, namely, antiviral agents and pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome, pharmaceutical preparations for the treatment of bacterial infections, namely, dermatological pharmaceutical preparations for the treatment of bacterial skin infections, and pharmaceutical preparations for the treatment of fungal infections.

Classification kind code

11

Class [040]
Processing of biopharmaceutical materials for the preparation and processing of chemical additives for use in the manufacture of medicaments, for the preparation and processing of reactive antibodies for scientific purposes, for the preparation and processing of monoclonal antibodies for scientific and medical research; Custom manufacturing of biopharmaceuticals.

Classification kind code

11

Class [042]
Research in chemistry and biology; biochemical research and development; conducting medical research for others; clinical trials; scientific research in the field of pharmacology, pharmaceuticals and biochemistry; laboratory research in the field of pharmaceuticals and nutraceuticals; consulting services in the field of pharmaceutical research and biochemistry; chemical services; biologist services; chemical analyses; preparation of biological samples for testing and analysis in research laboratories.

Classification kind code

11

Class [044]
Information, advisory and consultancy services in the biopharmaceutical field; information, consultancy and consultancy services in the field of medical treatment services.

Classification kind code

11

Mark Details

Serial Number

2069670

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 5th Apr 2022		Search Recorded
Submitted for opposition 20
on 5th Apr 2022		Examiner's First Report
Submitted for opposition 223
on 5th Apr 2022		Total Provisional Refusal
Submitted for opposition 256
on 11th Oct 2021		Notification of Possible Opposition Sent
Submitted for opposition 48
on 24th Feb 2021		Agent Changed
Submitted for opposition 257
on 10th Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 9th Dec 2020		Created
Submitted for opposition 31
on 9th Dec 2020		Formalized
Submitted for opposition 228
on 15th Jul 2020		International Registration
Submitted for opposition 30
on 15th Jul 2020		Filed